Asthma clinical trials in Missouri
11 studies for Asthma are looking for participants at sites in Missouri.
Cities in Missouri
A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)
- GSK Investigational Site, Columbia
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07645248ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
- Enveda Investigative Site, St Louis
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 24, 2026 · NCT07301255A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- Washington University School of Medicine, St Louis
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Sep 22, 2026 · NCT06977581Resources and Education for Addressing Chronic Health (REACH)
- WashU School of Medicine, St Louis
Recruiting
Ages 3 to 18 · All sexes · Updated Sep 21, 2026 · NCT07819747CHEST: A Collaboration With Community HEalth Centers to Implement SmarT for Asthma
- Affinia healthcare, 2220 Lemp Ave, St Louis
- Affinia healthcare, 1717 Biddle Street, St Louis
- Affinia healthcare, 4414 North Florissant Avenue, St Louis
- and 4 more
RecruitingPhase 4
Ages 12 and older · All sexes · Updated Sep 10, 2026 · NCT07241117A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
- Teva Investigational Site 12149, Columbia
- Teva Investigational Site 12108, St Louis
- Teva Investigational Site 12089, St Louis
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Aug 31, 2026 · NCT06664619A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
- Research Site, Columbia
RecruitingPhase 2
Ages 4 to 11 · All sexes · Updated Aug 27, 2026 · NCT07525375Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
- Research Site, Kansas City
- Research Site, St Louis
RecruitingPhase 3
Ages 12 to 17 · All sexes · Updated Aug 13, 2026 · NCT06307665A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma
- Research site, Kansas City
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Jul 28, 2026 · NCT07532265Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
- GSK Investigational Site, St Louis
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 2, 2026 · NCT06979323Individualizing Treatment for Asthma in Primary Care (Full Study)
- University of Missouri, Columbia
RecruitingPhase 4
Ages 13 to 75 · All sexes · Updated Oct 29, 2025 · NCT07052942From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.